Donald J. Ogilvie - Cancer Research UK Manchester Institute Drug Discovery Unit, University of Manchester

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 117 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure Legends 1-5 from Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background

Barry R. Davies, Hannah Greenwood, Phillippa Dudley,Claire Crafter, De-Hua Yu,Jingchuan Zhang,Jing Li, Beirong Gao, Qunsheng Ji,Juliana Maynard, Sally-Ann Ricketts, Darren Cross, Sabina Cosulich, Christine C. Chresta, Ken Page, James Yates,Clare Lane, Rebecca Watson, Richard Luke,Donald Ogilvie,Martin Pass

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 1 from Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background

Barry R. Davies, Hannah E. Greenwood,Phillippa Dudley,Claire Crafter, Dehua Yu, Jingchuan Zhang,Jing Li,Beirong Gao, Qunsheng Ji,Juliana Maynard,Sally‐Ann Ricketts,Darren A.E. Cross,Sabina Cosulich, Christine C. Chresta,Ken Page,James Yates,Clare Lane,Rebecca Watson,Richard Luke,Donald Ogilvie,Martin Pass

openalex

Cited0Views0Bibtex

Supplementary Figure 2 from Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background

Barry R. Davies, Hannah E. Greenwood,Phillippa Dudley,Claire Crafter, Dehua Yu, Jingchuan Zhang,Jing Li,Beirong Gao, Qunsheng Ji,Juliana Maynard,Sally‐Ann Ricketts,Darren A.E. Cross,Sabina Cosulich,Christine C. Chresta,Ken Page,James Yates,Clare Lane,Rebecca Watson,Richard Luke,Donald Ogilvie,Martin Pass

openalex

Cited0Views0Bibtex

Supplementary Figure 4 from Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background

Barry R. Davies, Hannah E. Greenwood,Phillippa Dudley,Claire Crafter, Dehua Yu,Jingchuan Zhang,Jing Li,Beirong Gao, Qunsheng Ji,Juliana Maynard,Sally‐Ann Ricketts,Darren A.E. Cross,Sabina Cosulich, Christine C. Chresta,Ken Page,James Yates,Clare Lane,Rebecca Watson,Richard Luke,Donald Ogilvie,Martin Pass

openalex（2023）

Cited0Views0Bibtex

Supplementary Data from AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer

D. Mark Hickinson,Teresa Klinowska,Georgina Speake,John Vincent,Cath Trigwell,Judith Anderton,Sarah R. Beck,Gayle Marshall,Sara Davenport,Rowena Callis, E.N. Clare Mills, Konstantina Grosios, Pete Smith,Bernard Barlaam, Robert W. Wilkinson,Donald Ogilvie

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure Legend from Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, Against VEGFR-1 and Members of the Structurally Related PDGFR Family

Sandra R. Brave,Kirsty Ratcliffe, Zena Wilson, Neil H. James, Sue Ashton, A. Martin Wainwright,Jane Kendrew, Phillippa Dudley, Nicola Broadbent,Graham Sproat, Siân Taylor, C.O. Barnes, Jeffrey C. Silva, Charles L. Farnsworth, Laurent Hennequin,Donald Ogilvie, Juliane M. Jürgensmeier,Masabumi Shibuya, Stephen R. Wedge, Simon T. Barry

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn